Elon Musk’s company, Neuralink, announced aggressive production targets for its Brain-Computer Interface (BCI) devices. The implant aims to restore function for people with severe conditions, such as a spinal cord injury. Historically, the primary limitations for BCI technology adoption have included signal noise, the need for extensive calibration, and challenges with real-world usability outside of clinical settings. Frequently Asked QuestionsQ1: What is the primary medical application of the Neuralink Brain-Computer Interface? nih.gov – The impact of non-invasive brain-computer interface technology on the therapeutic effect of patients with spinal cord injury.

Source: dna January 02, 2026 09:58 UTC